home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Cardiovascular Safety in Drug Development: State-of-the-art Assessments

 
  November 05, 2010  
     
 
L'Enfant Plaza Hotel , Washington, DC
Apr 13 2011 8:00AM - Apr 15 2011 5:00PM


Improve Your Safety Analysis During Drug Development
and Analyze and Mitigate Potential Risks.
Participate in debate-style presentations and hear commentary and
presentations from international industry, academic, and regulatory
speakers to help you optimize your cardiovascular safety assessment
 
TUTORIAL
April 13, 2011, 1:30-5:00 pm
An Introduction to Clinical Assessment of QT Prolongation in Drug Development
Preregistration is required.
 
Event Code:
11009

 
 
 
Organized by: DIA
Invited Speakers: Call Contact
 
Deadline for Abstracts: Call contact
 
Registration:
EVENT INFORMATION
Contact Rachel Minnick, Program Developer, Phone +1.215.442.6131
Fax +1.215.442.6199,
E-mail: rachel.minnick@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.